Dechra Pharmaceuticals PLC Result of AGM (6478E)

TIDMDPH

RNS Number : 6478E

Dechra Pharmaceuticals PLC

19 October 2018

Date: 19 October 2018

Dechra(R) Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

AGM Meeting Date: 10.30 am on 19 October 2018

Issued Share Capital at meeting date: 102,336,635

Number of shareholders in attendance: 9

All resolutions were passed on a show of hands.

Details of the proxy voting instructions lodged prior to the AGM are set out below:

 
 Resolution (No. as noted                 Total For (1)         Total Against       Withheld 
  on proxy form)                                                                     (2) 
                                          No. of       % of     No. of      % of    No. of votes 
                                           votes        vote     votes       vote 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 1: 
  To receive the accounts, 
  the Strategic Report, 
  the Directors' Report 
  and the Auditor's Report                73,623,740   95.88    3,162,913   4.12         377,261 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 2: 
  To approve the Directors' 
  Remuneration Report                     76,045,670   98.58    1,092,914   1.42          25,330 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 3: 
  To declare a final dividend             77,160,743   100.00       3,172   0.00               0 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 4: 
  To re-elect William 
  Anthony Rice                            71,931,907   93.24    5,212,000   6.76          20,007 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 5: 
  To re-elect Ian Page                    76,265,790   98.84      898,039   1.16              86 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 6: 
  To re-elect Richard 
  Cotton                                  76,089,363   98.61    1,074,466   1.39              86 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 7: 
  To re-elect Anthony 
  Griffin                                 76,248,926   98.81      914,902   1.19              86 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 8: 
  To re-elect Julian Heslop               76,471,131   99.10      692,698   0.90              86 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 9: 
  To re-elect Ishbel Macpherson           76,540,810   99.22      603,098   0.78          20,007 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 10: 
  To re-elect Lawson Macartney            76,643,113   99.33      520,716   0.67              86 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 11: 
  To re-appoint PricewaterhouseCoopers 
  as external auditor 
  of the Company                          76,021,787   98.52    1,141,654   1.48             473 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 12: 
  To authorise the Audit 
  Committee to determine 
  the remuneration of 
  the external auditor                    76,655,223   99.34      508,169   0.66             523 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 13: 
  To authorise the Directors 
  to allot shares to specific 
  limits                                  75,498,018   97.84    1,664,325   2.16           1,572 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 14: 
  To disapply the pre-emption 
  rights                                  73,792,966   95.63    3,369,827   4.37           1,122 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 15: 
  To disapply additional 
  pre-emption rights                      73,637,601   95.43    3,523,885   4.57           2,428 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 16: 
  To authorise the Company 
  to purchase its own 
  shares                                  76,382,960   99.00      773,210   1.00           7,744 
                                         -----------  -------  ----------  ------  ------------- 
 Resolution 17: 
  To call general meetings 
  (other than an AGM) 
  on not less than 14 
  clear days' notice                      75,446,021   97.77    1,717,894   2.23               0 
                                         -----------  -------  ----------  ------  ------------- 
      Resolution 18: 
       (a) To approve the rules 
       of the Dechra Global 
       Save As You Earn Scheme 
       2018 (2018 SAYE Plan); 
       and 
       (b) To authorise the 
       Directors to adopt further 
       plans based on the 2018 
       SAYE Plan                          76,738,556   99.45      423,701   0.55           1,658 
                                         -----------  -------  ----------  ------  ------------- 
 

Notes

   1.   Includes discretionary votes. 

2. A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

3. Resolutions 1 to 13 and Resolution 18 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.

4. Resolutions 14 to 17 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.

5. Votes tendered in respect of 77,163,915 shares representing 75.40% of the issued share capital.

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. The majority of Dechra's products are focused on key therapeutic categories where we have leading market positions, and many of our products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

RAGEAAENFDSPFFF

(END) Dow Jones Newswires

October 19, 2018 08:37 ET (12:37 GMT)